The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
MTD · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | HRMY | PFHO | INVA | MTD |
|---|---|---|---|---|
| Moat Score (0–100) | 82 | 83 (highest) | 82 | 82 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 95 (highest) | 83 | 45 | 72 |
| Pricing power | 99 | 100 (highest) | 98 | 97 |
| Returns on capital | 100 (highest) | 86 | 95 | — |
| Balance-sheet safety | 86 (highest) | 73 | 75 | 67 |
| Capital allocation | 32 | 71 | 100 (highest) | 91 |
| 9% above value if growth stopped today | 5% above value if growth stopped today | 36% below value if growth stopped today (largest discount to value if growth stopped today) | 182% above value if growth stopped today | |
| Market cap | $2.0B | $10.6M | $1.6B | $27.0B |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |